Atlas Trials

The Role of IMP3 Expression in Patients With Neuroblastoma

Clinical trial NCT01121419 · COMPLETED

Trial details

NCT number
NCT01121419
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Neuroblastoma
Start date
2008-01-01
Primary completion
2009-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.